首页> 外国专利> BIOMARKER FOR PREDICTING RISK OF DEVELOPING LUNG DISEASES AND USE THEREOF

BIOMARKER FOR PREDICTING RISK OF DEVELOPING LUNG DISEASES AND USE THEREOF

机译:预测发展中的肺部疾病的风险的生物标志物及其用途

摘要

The present invention relates to a marker composition for predicting a risk of developing lung diseases containing a Fibroblast Growth Factor 2 (FGF2) gene or proteins coded by the gene, a composition for predicting a risk of developing lung diseases containing an agent measuring the level of the gene or the protein, and a method of providing information for predicting a risk of developing lung diseases. A technology for predicting a risk of developing lung diseases according to the present invention is an in-advance method for predicting the risk of developing diseases before developing lung diseases by measuring the level of FGF2 to grasp a state of a lung function, thereby delaying diseases developing time or preventing developing diseases by a proper management after early diagnosis and prediction of lung diseases risk group. Even if the disease develops, the composition of the present invention is expected to be used in an early diagnosis of the lung diseases to lower a developing rate and increase a treating effect.;COPYRIGHT KIPO 2018
机译:本发明涉及一种含有成纤维细胞生长因子2(FGF2)基因或由该基因编码的蛋白质的用于预测发生肺部疾病的危险的标志物组合物,其包含一种可测量肺泡水平的试剂的用于预测肺部疾病的危险的组合物。基因或蛋白质,以及提供信息以预测发生肺部疾病的风险的方法。根据本发明的预测罹患肺部疾病的风险的技术是通过测量FGF2的水平以掌握肺功能的状态从而延迟疾病而在罹患肺部疾病之前预测罹患疾病的风险的提前方法。在早期诊断和预测肺部疾病风险组之后,通过适当的管理来发展时间或预防疾病的发展。即使疾病发展,本发明的组合物也有望用于肺部疾病的早期诊断,以降低发展速度并提高治疗效果。; COPYRIGHT KIPO 2018

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号